Doral is a brand name of quazepam, approved by the FDA in the following formulation(s):
DORAL (quazepam - tablet; oral)
Manufacturer: QUESTCOR PHARMS
Approval date: December 27, 1985
Strength(s): 15MG [RLD]
Has a generic version of Doral been approved?
No. There is currently no therapeutically equivalent version of Doral available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Doral. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Methods for reducing the risk of an adverse drug interaction in a patient suffering from insomnia
Patent 7,608,616
Issued: October 27, 2009
Inventor(s): Cartt; Steve
Assignee(s): Questcor Pharmaceuticals, Inc.
Disclosed herein is a method for treating a patient with Quazepam that reduces the risk of an adverse interaction between the Quazepam and drug that is a substrate of the cytochrome P450 enzyme isoform 2B6 (CYP2B6 substrate drug), e.g., Bupropion. The method includes determining if the patient to be treated with Quazepam is being treated with a CYP2B6 substrate drug, and prescribing or treating the patient with Quazepam based on the determination.Patent expiration dates:
- June 3, 2028✓
- June 3, 2028
See also...
- Doral Consumer Information (Wolters Kluwer)
- Doral Consumer Information (Cerner Multum)
- Doral Advanced Consumer Information (Micromedex)
- Quazepam Consumer Information (Wolters Kluwer)
- Quazepam Consumer Information (Cerner Multum)
- Quazepam Advanced Consumer Information (Micromedex)
No comments:
Post a Comment